日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy.

缺氧激活前药evofosfamide与多种放射疗法联合应用

Nytko Katarzyna J, Grgic Ivo, Bender Sabine, Ott Janosch, Guckenberger Matthias, Riesterer Oliver, Pruschy Martin